Skip to main content
. 2022 Sep 21;14(19):3917. doi: 10.3390/nu14193917

Table 5.

Changes in serum levels of insulin-like growth factor 1, follistatin, and brain-derived neurotropic factor during the intervention.

Group Baseline 24 Weeks p for Time Changes p for Groups
IGF-1 (mg/mL) B 102 ± 32 99 ± 32 0.292 −3 ± 13 0.316
S 101 ± 40 105 ± 33 0.589 4 ± 28
Follistatin (pg/mL) * B 1312 (711–1807) 1419 (868–1857) 0.675 68 (−316–319) 0.611
S 1091 (889–2106) 1232 (907–2225) 0.595 −38 (−149–366)
BDNF (pg/mL) B 23,667 ± 4452 23,011 ± 5020 0.511 −655 ± 4376 0.439
S 22,130 ± 4919 20,093 ± 6210 0.214 −2037 ± 6068

Data are mean ± SD or median (interquartile range). * log-transformed variables are used.